Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

BUY
$0.38 - $1.05 $43,027 - $118,890
113,229 Added 453.21%
138,213 $58,000
Q1 2022

May 17, 2022

SELL
$0.52 - $1.3 $6,261 - $15,653
-12,041 Reduced 32.52%
24,984 $17,000
Q4 2021

Feb 17, 2022

BUY
$0.66 - $1.18 $24,436 - $43,689
37,025 New
37,025 $24,000
Q2 2021

Sep 17, 2021

SELL
$1.31 - $2.14 $172,622 - $281,994
-131,773 Closed
0 $0
Q1 2021

May 19, 2021

BUY
$1.85 - $3.04 $243,780 - $400,589
131,773 New
131,773 $260,000

Others Institutions Holding HOTH

About Hoth Therapeutics, Inc.


  • Ticker HOTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,288,470
  • Market Cap $1.11M
  • Description
  • Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...
More about HOTH
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.